2025-02-27 |
2025-02-27 |
B
Purchase
|
KANEKO YASUNORI
Non-Executive Director
|
20,000
+238.1%
10.06
USD 201,200
|
20,000
+238.1%
|
10.06
|
USD 201,200
|
|
2025-02-27 |
2025-02-27 |
B
Purchase
|
ROSEN TERRY J
Chief Executive Officer
Executive Director
|
19,800
+0.8%
10.18
USD 201,465
|
19,800
+0.8%
|
10.18
|
USD 201,465
|
|
2025-02-20 |
2025-02-18 |
B
Purchase
|
GILEAD SCIENCES, INC.
Large shareholder
|
1,363,636
+4.5%
11.00
USD 14,999,996
|
1,363,636
+4.5%
|
11.00
|
USD 14,999,996
|
|
2025-01-03 |
2024-12-31 |
PS
Planned sale
|
Goeltz II Robert C.
Chief Financial Officer
Officer
|
3,594
-5.6%
15.00
USD 53,910
|
3,594
-5.6%
|
15.00
|
USD 53,910
|
|
2024-12-04 |
2024-12-02 |
PS
Planned sale
|
Azoy Alexander
Chief Accounting Officer
Officer
|
201
-1.0%
15.32
USD 3,079
|
201
-1.0%
|
15.32
|
USD 3,079
|
|
2024-08-15 |
2024-08-13 |
PS
Planned sale
|
Azoy Alexander
Chief Accounting Officer
Officer
|
1,357
-6.6%
14.97
USD 20,314
|
1,357
-6.6%
|
14.97
|
USD 20,314
|
|
2024-03-29 |
2024-03-27 |
PS
Planned sale
|
Jarrett Jennifer
Chief Operating Officer
Officer
|
11,551
-5.1%
17.55
USD 202,720
|
11,551
-5.1%
|
17.55
|
USD 202,720
|
|
2024-03-20 |
2024-03-18 |
S
Sale
|
Jarrett Jennifer
Chief Operating Officer
Officer
|
1,296
-0.6%
18.62
USD 24,132
|
1,296
-0.6%
|
18.62
|
USD 24,132
|
|
2024-03-20 |
2024-03-18 |
S
Sale
|
Jarrett Jennifer
Chief Operating Officer
Officer
|
12,153
-5.1%
17.84
USD 216,810
|
12,153
-5.1%
|
17.84
|
USD 216,810
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Jaen Juan C.
President
Officer
|
23,132
-1.9%
20.10
USD 464,953
|
23,132
-1.9%
|
20.10
|
USD 464,953
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Jarrett Jennifer
Chief Operating Officer
Officer
|
34,070
-12.4%
20.11
USD 685,148
|
34,070
-12.4%
|
20.11
|
USD 685,148
|
|
2024-02-28 |
2024-02-26 |
PS
Planned sale
|
Jaen Juan C.
President
Officer
|
3,900
-0.3%
20.06
USD 78,234
|
3,900
-0.3%
|
20.06
|
USD 78,234
|
|
2024-02-28 |
2024-02-26 |
PS
Planned sale
|
Jarrett Jennifer
Chief Operating Officer
Officer
|
24,555
-8.2%
20.07
USD 492,819
|
24,555
-8.2%
|
20.07
|
USD 492,819
|
|
2024-01-31 |
2024-01-29 |
B
Purchase
|
GILEAD SCIENCES, INC.
Large shareholder
|
15,238,095
+102.8%
21.00
USD 319,999,995
|
15,238,095
+102.8%
|
21.00
|
USD 319,999,995
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Jaen Juan C.
President
Executive Director
|
6,975
-0.6%
20.09
USD 140,128
|
6,975
-0.6%
|
20.09
|
USD 140,128
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Goeltz II Robert C.
Chief Financial Officer
Officer
|
2,004
-3.7%
20.00
USD 40,080
|
2,004
-3.7%
|
20.00
|
USD 40,080
|
|
2023-12-26 |
2023-12-22 |
PS
Planned sale
|
Jarrett Jennifer
Chief Operating Officer
Executive Director
|
21,521
-7.7%
17.76
USD 382,213
|
21,521
-7.7%
|
17.76
|
USD 382,213
|
|
2023-12-05 |
2023-12-01 |
PS
Planned sale
|
Azoy Alexander
Chief Accounting Officer
Officer
|
282
-2.4%
14.95
USD 4,216
|
282
-2.4%
|
14.95
|
USD 4,216
|
|
2023-09-26 |
2023-09-22 |
PS
Planned sale
|
Jarrett Jennifer
Chief Operating Officer
Executive Director
|
21,369
-6.6%
19.99
USD 427,166
|
21,369
-6.6%
|
19.99
|
USD 427,166
|
|
2023-07-31 |
2023-07-28 |
PS
Planned sale
|
Jarrett Jennifer
Chief Operating Officer
Executive Director
|
45,000
-11.8%
20.25
USD 911,250
|
45,000
-11.8%
|
20.25
|
USD 911,250
|
|